Selective distribution of oxysterols in atherosclerotic lesions and human plasma lipoproteins

References

• Berliner J.A., Navab M, Fogelman A.M., Frank J.S., Demer L.L., Edwards P.A., Watson A.D., Lusis A.J. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation 1995; 91: 2488–2496
   PubMed Web of Science ®Google Scholar
• Peng S.K., Hu B., Morin R.J. Angiotoxicity and atherogenicity of cholesterol oxides. Journal of Clinical Laboratory Analysis 1991; 5: 144–152
   PubMed Web of Science ®Google Scholar
• Guardiola F., Codony R., Addis P.B., Rafecas M., Boatella J. Biological effects of oxysterols: current status. Food Chemistry & Toxicology 1996; 34: 193–211
   PubMed Web of Science ®Google Scholar
• Morin R.J., Peng S.K. The role of cholesterol oxidation products in the pathogenesis of atherosclerosis. Annals of Clinical & Laboratory Science 1989; 19: 225–237
   PubMed Web of Science ®Google Scholar
• Hughes H., Mathews M., Lenz M.L., Guyton J.R. Cytotoxicity of oxidized LDL to porcine aortic smooth muscle cells is associated with the oxysterols 7-ketocholesterol and 7-hydroxycholesterol. Arteriosclererosis & Thrombosis 1994; 14: 1177–1185
   PubMedGoogle Scholar
• Clare K., Hardwick S.J., Carpenter K.L.H., Weeratunge N., Mitchinson M.J. Toxicity of oxysterols to human monocyte-macrophages. Atherosclerosis 1995; 118: 67–75
   PubMed Web of Science ®Google Scholar
• Wrensch M.R., Petrakis N.L., Gruenke L.D., Miike R., Ernster V.L., King E.B., Hauck W.W., Craig J.C., Goodson W.H. Breast fluid cholesterol and cholesterol β-epoxide concentrations in women with benign breast disease. Cancer Research 1989; 49: 2168–2174
   PubMed Web of Science ®Google Scholar
• Peng S.K., Taylor C.B., Hill J.C., Morin R.J. Cholesterol oxidation derivatives and arterial endothelial damage. Atherosclerosis 1985; 54: 121–133
   PubMed Web of Science ®Google Scholar
• Aupeix K., Weltin D., Mejia J.E., Christ M., Marchal J., Freyssinet J.M., Bischoff P. Oxysterol-induced apoptosis in human monocytic cell lines. Immunobiology 1995; 194: 415–428
   PubMed Web of Science ®Google Scholar
• Bakos J.T., Johnson B.H., Thompson E.B. Oxysterol-induced cell death in human leukemic T-cells correlates with oxysterol binding protein occupancy and is independent of glucocorticoid-induced apoptosis. Journal of Steroid Biochemistry and Molecular Biology 1993; 46: 415–426
   PubMed Web of Science ®Google Scholar
• Christ M., Luu B., Mejia J.E., Moosbrugger I., Bischoff P. Apoptosis induced by oxysterols in murine lymphoma cells and in normal thymocytes. Immunology 1993; 78: 455–460
   PubMed Web of Science ®Google Scholar
• Berliner J.A., Territo M.C., Sevanian A., Ramin S., Kim J.A., Ramshad B., Esterson M. Minimally modified low density lipoprotein stimulates monocyte endothelial cell interactions. Journal of Clinical Investigation 1990; 85: 1260–1266
   PubMed Web of Science ®Google Scholar
• Kritharides L., Kus M., Brown A.J., Jessup W., Dean R.T. Hydroxypropyl-β cyclodextrin-mediated efflux of 7-ketocholesterol from macrophage foam cells. Journal of Biological Chemistry 1996; 271: 27450–27455
   PubMed Web of Science ®Google Scholar
• Carpenter K.L.H., Taylor S.E., van der Veen C., Williamson B.K., Ballantine J.A., Mitchinson M.J. Lipids and oxidized lipids in human atherosclerotic lesions at different stages of development. Biochimica Biophysica Acta 1995; 1256: 141–150
   PubMed Web of Science ®Google Scholar
• Carpenter K.L.H., Taylor S.E., Ballantine J.A., Fusell B., Halliwell B., Mitchinson M.J. Lipids and oxidized lipids in human atheroma and normal aorta. Biochimica Biophysica Acta 1993; 1167: 121–130
   PubMed Web of Science ®Google Scholar
• Jacobson M.S. Cholesterol oxides in Indian ghee: possible cause of unexplained high risk of atherosclerosis in Indian immigrant populations. Lancet 1987; 656–656
   PubMed Web of Science ®Google Scholar
• Lui K., Cuddy T.E., Pierce G.N. Oxidative status of lipoproteins in coronary disease patients. American Heart Journal 1992; 123: 285–285
   PubMed Web of Science ®Google Scholar
• Zieden B., Diczfalusy U. Higher 7β-hydroxycholesterol in high cardiovascular risk population. Atherosclerosis 1997; 134: 172–172
   Web of Science ®Google Scholar
• Zieden B., Kaminskas M., Kristenson Z., Kucinskiene B., Vessby A.G., Diczfalusy U., Olsson. Increased plasma 7β-hydroxycholesterol concentrations in a population with a high risk for cardiovascular disease. Arteriosclerosis Thrombosis and Vascular Biology 1999; 19: 967–971
   PubMed Web of Science ®Google Scholar
• Lizard G., Monier S., Cordelet C., Gesquiere L., Deckert V., Gueldry S., Lagrost L., Gambert P. Characterization and comparison of the mode of cell death, apoptosis versus necrosis, induced by 7β-hydroxycholesterol and 7-ketocholesterol in the cells of the vascular wall. Arteriosclerosis Thrombosis and Vascular Biology 1999; 19: 1190–1200
   PubMed Web of Science ®Google Scholar
• Sevanian A., McLeod L.L. Cholesterol autoxidation in phospholipid membrane bilayers. Lipids 1987; 22: 627–636
   PubMed Web of Science ®Google Scholar
• van de Bovenkamp P., Kosmeijer-Schuil T.G., Katan M.B. Quantification of oxysterols in Dutch foods: egg products and mixed diets. Lipids 1988; 23: 1079–1085
   PubMed Web of Science ®Google Scholar
• Bjorkhem I., Lutjohann D., Breuer O., Sakinis A., Wennmalm A. Importance of a novel oxidative mechanism for elimination of brain cholesterol. Turnover of cholesterol and 24(S)-hydroxycholesterol in rat brain as measured with 18O2 techniques in vivo and in vitro. Journal of Biological Chemistry 1997; 272: 30178–30184
   PubMed Web of Science ®Google Scholar
• Hodis H.N., Chauhan A., Hashimoto S., Crawford D.W., Sevanian A. Probucol reduces plasma and aortic wall oxysterol levels in cholesterol fed rabbits independently of its plasma cholesterol lowering effect. Atherosclerosis 1992; 96: 125–134
   PubMed Web of Science ®Google Scholar
• Freyschuss A., Stiko-Rahm A., Swedenborg J., Henriksson P., Bjorkhem I., Berglund L., Nilsson J. Antioxidant treatment inhibits the development of intimal thickening after balloon injury of the aorta in hypercholesterolemic rabbits. Journal of Clinical Investigation 1993; 91: 1282–1288
   PubMed Web of Science ®Google Scholar
• Breuer O., Bjorkhem I. Use of an 18O2 inhalation technique and mass isotopomer distribution analysis to study oxygenation of cholesterol in rat. Evidence for in vivo formation of 7-oxo-, 7β-hydroxy-, 24-hydroxy-, and 25-hydroxycholesterol. Journal of Biological Chemistry 1995; 270: 20278–20284
   PubMed Web of Science ®Google Scholar
• Sevanian A., Seraglia R., Traldi P., Rossato P., Ursini F., Hodis H. Analysis of plasma cholesterol oxidation products using gas- and high-performance liquid chromatography/mass spectrometry. Free Radicals in Biology & Medicine 1994; 17: 397–409
   PubMed Web of Science ®Google Scholar
• Dyer R.G., Stewart M.W., Mitcheson J., George K., Alberti M.M., Laker M.F. 7-ketocholesterol, a specific indicator of lipoprotein oxidation, and malondialdehyde in non-insulin dependent diabetes and peripheral vascular disease. Clinica Chimica Acta 1997; 260: 1–13
   PubMed Web of Science ®Google Scholar
• Addis P.B., Emanuel H.A., Bergmann S.D., Zavoral J.H., Capillary G.C. Quantification of cholesterol oxidation products in plasma lipoproteins of fasted humans. Free Radicals in Biology & Medicine 1989; 17: 179–182
   Google Scholar
• Aviram M. Plasma lipoprotein separation by discontinuous density gradient ultracentrifugation in hyperlipoproteinemic patients. Biochemistry of Medicine 1983; 30: 111–118
   PubMed Web of Science ®Google Scholar
• Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Buege J.A., Aust S.D. Microsomal lipid peroxidation. Methods in Enzymology 1978; 52: 302–310
   PubMedGoogle Scholar
• Brown A.J., Jessup W. Oxysterols and atherosclerosis. Atherosclerosis 1999; 142: 1–28
   PubMed Web of Science ®Google Scholar
• Brown A.J., Dean R.T., Jessup W. Free and esterified oxysterol: formation during copper-oxidation of low density lipoprotein and uptake by macrophages. Journal of Lipid Research 1996; 37: 320–335
   PubMed Web of Science ®Google Scholar
• Jialal I., Freeman D.A., Grundy S.M. Varying susceptibility of different low density lipoprotein to oxidative modification. Arteriosclerosis & Thrombosis 1991; 11: 482–488
   PubMed Web of Science ®Google Scholar
• Bhadra S., Marshad M.A.Q., Rymaszwski Z., Norman E., Wherley R., Subbiah M.T.R. Oxidation of cholesterol moiety of low density lipoprotein in the presence of human endothelial cells or Cu+2 ions: identification of major products and their effects. Biochemical & Biophysical Research Communications 1991; 176: 431–440
   PubMed Web of Science ®Google Scholar
• Tanaka M., Kanamaru S. Capillary gas chromatography quantification of cholesterol in copper-oxidised low-density lipoproteins. Biology & Pharmacology Bulletin 1993; 16: 538–543
   PubMed Web of Science ®Google Scholar
• Carpenter KL, Wilkins GM, Fussell B, Ballantine JA, Taylor SE, Mitchinson MJ, Leake DS. Production of oxidized lipids during modification of low-density lipoprotein by macrophages or copper. Biochemical Journal 1994; 304: 625–633
   PubMed Web of Science ®Google Scholar
• Malavasi B., Rasetti M.F., Roma P., Fogliatto R., Allevi P., Catapano A.L., Galli G. Evidence for the presence of 7-hydroperoxycholest-5-en-3β-ol in oxidised human LDL. Chemistry & Physics of Lipids 1992; 62: 209–214
   PubMed Web of Science ®Google Scholar
• Brown A.J., Leong S.L., Dean R.T., Jessup W. 7-Hydroperoxy-cholestesterol and its products in oxidized low density lipoprotein and human atherosclerotic plaque. Journal of Lipid Research 1997; 38: 1730–1745
   PubMed Web of Science ®Google Scholar
• Belinky P.A., Aviram M., Fuhrman B., Rosenblat M., Vaya J. The antioxidative effects of the isoflavan glabridin on endogenous constituents of LDL during its oxidation. Atherosclerosis 1998; 137: 49–61
   PubMed Web of Science ®Google Scholar
• Harik-Khan R., Holmes R.P. Estimation of 26-hydroxycholesterol in serum by high-performance liquid chromatography and its measurement in patients with atherosclerosis. Journal of Steroid Biochemistry 1990; 36: 351–355
   PubMedGoogle Scholar
• Mol M.J., de Rijke Y.B., Demacker P.N., Stalenhoef A.F. Plasma levels of lipid and cholesterol oxidation products and cytokines in diabetes mellitus and cigarette smoking: effects of vitamin E treatment. Atherosclerosis 1997; 129: 169–176
   PubMed Web of Science ®Google Scholar
• van der Vijver L.P., Steyger R., van Poppel G., Boer J.M., Kruijssen D.A., Seidell J.C., Princen H.M. Autoantibodies against MDA-LDL in subjects with severe and minor atherosclerosis and healthy population controls. Atherosclerosis 1996; 22: 245–253
   Google Scholar
• Salonen J.T., Nyyssonen K., Salonen R., Porkkala-Sarataho E., Tuomainen T.P., Diczfalusy U., Bjorkhem I. Lipoprotein oxidation and progression of carotid atherosclerosis. Circulation 1997; 95: 840–845
   PubMed Web of Science ®Google Scholar
• van Poppel G., Kok F.J., Jahanns E., Kosmeijer T. Plasma oxysterols and coronary atherosclerosis: a case control study. International Congress on Nutrition (Adelaide) 1993; 3: 795–795, 758
   Google Scholar
• Crisby M., Nilsson J., Kostulas V., Bjorkhem I., Diczfalusy U. Localization of sterol 27-hydroxylase immuno-reactivity in human atherosclerotic plaques. Biochimica Biophysica Acta 1997; 1344: 278–285
   PubMed Web of Science ®Google Scholar
• Lund E., Andersson O., Zhang J., Babiker A., Ahlborg G., Diczfalusy U., Einarsson K., Sjovall J., Bjorkhem I. Importance of a novel oxidative mechanism for elimination of intracellular cholesterol in humans. Arteriosclerosis Thrombosis & Vascular Biology 1996; 16: 208–212
   PubMed Web of Science ®Google Scholar